Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

计划入组 85 人 · 首次发布于 2009 年 6 月 9 日

A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

计划入组 5 人 · 首次发布于 2009 年 4 月 9 日

Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

计划入组 29 人 · 首次发布于 2007 年 1 月 23 日

Lonafarnib(Zokinvy)

C₂₇H₃₁Br₂ClN₄O₂

icmt inhibitors (cancer/Hutchinson Gilford progeria syndrome)

Biologics by McKesson Selected as Exclusive Pharmacy for Progeria Drug ZOKINVY

FDA Authorizes Phase 2a Trial of Progerinin for Hutchinson-Gilford Progeria Syndrome

Sentynl Therapeutics Partners with myTomorrows to Expand Global Access to Rare Disease Treatments